4.8 Review

Whole Blood Mycobacterial Growth Assays for Assessing Human Tuberculosis Susceptibility: A Systematic Review and Meta-Analysis

Journal

FRONTIERS IN IMMUNOLOGY
Volume 12, Issue -, Pages -

Publisher

FRONTIERS MEDIA SA
DOI: 10.3389/fimmu.2021.641082

Keywords

tuberculosis; mycobacterial growth assay; mycobacterial growth inhibition assay; MGIA; susceptibility; risk

Categories

Funding

  1. Wellcome Trust [057434/Z/99/Z, 070005/Z/02/Z, 078340/Z/05/Z, 105788/Z/14/Z, 201251/Z/16/Z]
  2. UK-AID DFID-CSCF
  3. Joint Global Health Trials Scheme [MR/K007467/1]
  4. UK Medical Research Council
  5. UK Department of Health and Social Care through the National Institute of Health Research (NIHR)
  6. Wellcome
  7. STOP TB partnership's TB REACH initiative - Government of Canada
  8. Bill & Melinda Gates Foundation [OPP1118545, W5_PER_CDT1_PRISMA]
  9. CONCYTEC/FONDECYT [E067-2020-02-01, 083-2020]
  10. charity IFHAD: Innovation For Health And Development
  11. UK Foreign, Commonwealth and Development Office

Ask authors/readers for more resources

Whole blood mycobacterial growth assays (WBMGA) have the potential for evaluating tuberculosis vaccines and identifying individuals at risk of tuberculosis. Studies have shown significant associations between WBMGA results and correlates of tuberculosis susceptibility, but no direct evidence on whether WBMGA results can predict actual susceptibility to tuberculosis infection or disease is available. Further optimization, standardization, and prospective studies are recommended to determine if WBMGA can predict susceptibility to tuberculosis disease.
Background Whole blood mycobacterial growth assays (WBMGA) quantify mycobacterial growth in fresh blood samples and may have potential for assessing tuberculosis vaccines and identifying individuals at risk of tuberculosis. We evaluated the evidence for the underlying assumption that in vitro WBMGA results can predict in vivo tuberculosis susceptibility. Methods A systematic search was done for studies assessing associations between WBMGA results and tuberculosis susceptibility. Meta-analyses were performed for eligible studies by calculating population-weighted averages. Results No studies directly assessed whether WBMGA results predicted tuberculosis susceptibility. 15 studies assessed associations between WBMGA results and proven correlates of tuberculosis susceptibility, which we divided in two categories. Firstly, WBMGA associations with factors believed to reduce tuberculosis susceptibility were statistically significant in all eight studies of: BCG vaccination; vitamin D supplementation; altitude; and HIV-negativity/therapy. Secondly, WBMGA associations with probable correlates of tuberculosis susceptibility were statistically significant in three studies of tuberculosis disease, in a parasitism study and in two of the five studies of latent tuberculosis infection. Meta-analyses for associations between WBMGA results and BCG vaccination, tuberculosis infection, tuberculosis disease and HIV infection revealed consistent effects. There was considerable methodological heterogeneity. Conclusions The study results generally showed significant associations between WBMGA results and correlates of tuberculosis susceptibility. However, no study directly assessed whether WBMGA results predicted actual susceptibility to tuberculosis infection or disease. We recommend optimization and standardization of WBMGA methodology and prospective studies to determine whether WBMGA predict susceptibility to tuberculosis disease.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available